In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing.

Published in: Pharmaceutics (2020)

Computer simulation platforms need to improve their mechanistic physiologically based pharmacokinetic (PBPK) modeling, and if prospectively validated within a small percentage of error from the observed clinical data, they can be valuable tools in bioequivalence (BE) testing and formulation development.

Keyphrases

drug delivery
electronic health record
molecular docking
deep learning
big data
molecular dynamics simulations